JP2022003044A5 - - Google Patents

Download PDF

Info

Publication number
JP2022003044A5
JP2022003044A5 JP2021147954A JP2021147954A JP2022003044A5 JP 2022003044 A5 JP2022003044 A5 JP 2022003044A5 JP 2021147954 A JP2021147954 A JP 2021147954A JP 2021147954 A JP2021147954 A JP 2021147954A JP 2022003044 A5 JP2022003044 A5 JP 2022003044A5
Authority
JP
Japan
Prior art keywords
compound
double
deoxyribosyl
stranded oligonucleotide
ribosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021147954A
Other languages
English (en)
Other versions
JP2022003044A (ja
JP7383674B2 (ja
Filing date
Publication date
Priority claimed from JP2019103109A external-priority patent/JP7334069B2/ja
Application filed filed Critical
Publication of JP2022003044A publication Critical patent/JP2022003044A/ja
Publication of JP2022003044A5 publication Critical patent/JP2022003044A5/ja
Priority to JP2023133115A priority Critical patent/JP2023179406A/ja
Application granted granted Critical
Publication of JP7383674B2 publication Critical patent/JP7383674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (25)

  1. 以下の式の化合物であって、
    Figure 2022003044000001
    ここでR は水素、アルキル、アルケニル、アルキニル、メトキシ、メタンチオール、メタンセレノ、ハロゲン、シアノ、またはアジドであり、
    ここで波線はリボシル、2’-デオキシリボシル、または2’,3’-ジデオキシリボシルの部分への結合を示し、
    ここでリボシル、2’-デオキシリボシル、または2’,3’-ジデオキシリボシルの部分の5’ヒドロキシル基は遊離形態もしくは一リン酸塩、二リン酸塩、または三リン酸塩の基に結合され、
    ここで前記化合物はRNAのオリゴヌクレオチド鎖またはDNAのオリゴヌクレオチド鎖に取り込まれる、化合物。
  2. 波線はリボシルまたは2’-デオキシリボシルの部分への結合を示す、請求項1に記載の化合物。
  3. は水素またはハロゲンである、請求項1または2に記載の化合物。
  4. はフルオロである、請求項1または2に記載の化合物。
  5. は水素である、請求項1または2に記載の化合物。
  6. 以下の構造を有する、請求項1に記載の化合物。
    Figure 2022003044000002
  7. 以下の構造を有する、請求項1に記載の化合物。
    Figure 2022003044000003
  8. は水素またはハロゲンであり、
    波線はリボシルまたは2’-デオキシリボシルの部分への結合を示し、および
    前記リボシルまたは2’-デオキシリボシルの部分の5’ヒドロキシル基は一リン酸塩、二リン酸塩、または三リン酸塩の基に結合される、請求項1に記載の化合物。
  9. 前記リボシルまたは2’-デオキシリボシルの部分の5’ヒドロキシル基は三リン酸塩の基に結合される、請求項1または8に記載の化合物。
  10. は水素であり、
    波線はリボシルまたは2’-デオキシリボシルの部分への結合を示し、および
    前記リボシルまたは2’-デオキシリボシルの部分の5’ヒドロキシル基は三リン酸塩の基に結合される、請求項1に記載の化合物。
  11. 波線はリボシルの部分への結合を示し、前記化合物はRNAのオリゴヌクレオチド鎖に取り込まれる、請求項1-5のいずれか1つに記載の化合物。
  12. 波線は2’-デオキシリボシルの部分への結合を示し、前記化合物はDNAのオリゴヌクレオチド鎖に取り込まれる、請求項1-5のいずれか1つに記載の化合物。
  13. 以下の構造を有する化合物。
    Figure 2022003044000004
  14. 以下の構造を有する化合物。
    Figure 2022003044000005
  15. 第1の鎖と第2の鎖を含む二本鎖オリゴヌクレオチドであって、ここで、
    (a)前記第1の鎖は以下の式における第1の化合物を含み、
    Figure 2022003044000006
    ここでR は水素、アルキル、アルケニル、アルキニル、メトキシ、メタンチオール、メタンセレノ、ハロゲン、シアノ、またはアジドであり、
    ここで波線は2’-デオキシリボシルの部分への結合を示し、および
    (b)前記第2の鎖は、以下の群から選択される第2の化合物を含み、
    Figure 2022003044000007
    ここで波線は2’-デオキシリボシルの部分への結合を示す、二本鎖オリゴヌクレオチド。
  16. 第1の化合物と第2の化合物は二本鎖オリゴヌクレオチド中で塩基対を形成する、請求項15に記載の二本鎖オリゴヌクレオチド。
  17. は水素またはハロゲンである、請求項16または17に記載の二本鎖オリゴヌクレオチド。
  18. は水素である、請求項16または17に記載の二本鎖オリゴヌクレオチド。
  19. はハロゲンである、請求項16または17に記載の二本鎖オリゴヌクレオチド。
  20. ハロゲンはフルオロである、請求項19に記載の二本鎖オリゴヌクレオチド。
  21. 第2の化合物は以下である、請求項16-20のいずれか1つに記載の二本鎖オリゴヌクレオチド。
    Figure 2022003044000008
  22. 第2の化合物は以下である、請求項21に記載の二本鎖オリゴヌクレオチド。
    Figure 2022003044000009
  23. 第2の化合物は以下である、請求項21に記載の二本鎖オリゴヌクレオチド。
    Figure 2022003044000010
  24. 第2の化合物は以下である、請求項21に記載の二本鎖オリゴヌクレオチド。
    Figure 2022003044000011
  25. 第2の化合物は以下である、請求項21に記載の二本鎖オリゴヌクレオチド。
    Figure 2022003044000012
JP2021147954A 2013-08-08 2021-09-10 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法 Active JP7383674B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023133115A JP2023179406A (ja) 2013-08-08 2023-08-17 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361863649P 2013-08-08 2013-08-08
US61/863,649 2013-08-08
JP2019103109A JP7334069B2 (ja) 2013-08-08 2019-05-31 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019103109A Division JP7334069B2 (ja) 2013-08-08 2019-05-31 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023133115A Division JP2023179406A (ja) 2013-08-08 2023-08-17 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Publications (3)

Publication Number Publication Date
JP2022003044A JP2022003044A (ja) 2022-01-11
JP2022003044A5 true JP2022003044A5 (ja) 2022-06-10
JP7383674B2 JP7383674B2 (ja) 2023-11-20

Family

ID=52461970

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016533480A Pending JP2016531122A (ja) 2013-08-08 2014-08-08 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法
JP2019103109A Active JP7334069B2 (ja) 2013-08-08 2019-05-31 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法
JP2021147954A Active JP7383674B2 (ja) 2013-08-08 2021-09-10 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法
JP2023133115A Pending JP2023179406A (ja) 2013-08-08 2023-08-17 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016533480A Pending JP2016531122A (ja) 2013-08-08 2014-08-08 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法
JP2019103109A Active JP7334069B2 (ja) 2013-08-08 2019-05-31 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023133115A Pending JP2023179406A (ja) 2013-08-08 2023-08-17 非天然ヌクレオチドの取り込みによるインビトロの核酸の部位特異的な酵素標識のための方法

Country Status (16)

Country Link
US (4) US10626138B2 (ja)
EP (3) EP3656781A1 (ja)
JP (4) JP2016531122A (ja)
AU (4) AU2014306271A1 (ja)
CA (1) CA2920527A1 (ja)
DK (1) DK3041854T3 (ja)
EA (2) EA038576B1 (ja)
ES (1) ES2773547T3 (ja)
HR (1) HRP20200250T1 (ja)
HU (1) HUE048710T2 (ja)
LT (1) LT3041854T (ja)
PL (1) PL3041854T3 (ja)
PT (1) PT3041854T (ja)
RS (1) RS59991B1 (ja)
SI (1) SI3041854T1 (ja)
WO (1) WO2015021432A1 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物,以及包括其的组合物和方法
EP3943607A1 (en) 2014-04-09 2022-01-26 The Scripps Research Institute Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
PL415967A1 (pl) * 2016-01-29 2017-07-31 Univ Warszawski 5'-tiofosforanowe analogi końca 5' mRNA (kapu), sposób ich otrzymywania i zastosowanie
ES2929047T3 (es) 2016-06-24 2022-11-24 Scripps Research Inst Transportador de nucleósido trifosfato novedoso y usos del mismo
AR112756A1 (es) * 2017-07-11 2019-12-11 Synthorx Inc Incorporación de nucleótidos no naturales, y su método
US20200224234A1 (en) * 2017-07-11 2020-07-16 The Scripps Research Institute Incorporation of unnatural nucleotides and methods of use in vivo thereof
KR20200035092A (ko) 2017-08-03 2020-04-01 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
TW202045208A (zh) 2019-02-06 2020-12-16 美商欣爍克斯公司 Il-2結合物及其使用方法
CN110478950B (zh) * 2019-05-14 2021-08-06 江苏四新科技应用研究所股份有限公司 一种用于透明液体洗涤剂的消泡剂
AU2020291535A1 (en) * 2019-06-14 2022-01-20 The Scripps Research Institute Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
TW202120128A (zh) 2019-08-15 2021-06-01 美商欣爍克斯公司 使用il-2接合物之免疫腫瘤學組合療法
TW202122401A (zh) 2019-08-23 2021-06-16 美商欣爍克斯公司 新穎之il-15接合物及其用途
BR112022003335A2 (pt) 2019-09-10 2022-05-24 Synthorx Inc Conjugados de il-2 e métodos de uso para tratar doenças autoimunes
TW202131952A (zh) 2019-11-04 2021-09-01 美商欣爍克斯公司 介白素10接合物及其用途
AU2020395113A1 (en) 2019-12-02 2022-06-09 Shape Therapeutics Inc. Therapeutic editing
JP2023518105A (ja) * 2019-12-30 2023-04-27 源點生物科技股▲フン▼有限公司 酵素を使用して核酸配列を調製するための方法
KR20220104057A (ko) * 2019-12-30 2022-07-25 위안디안 바이오랩스 컴퍼니 리미티드 효소를 이용한 핵산 서열 제조 장치 및 방법
CA3183834A1 (en) 2020-06-25 2021-12-30 Giovanni Abbadessa Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies
EP4225376A1 (en) 2020-10-09 2023-08-16 Synthorx, Inc. Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
CA3194880A1 (en) 2020-10-09 2022-04-14 Carolina E. CAFFARO Immuno oncology therapies with il-2 conjugates
WO2022123947A1 (ja) * 2020-12-08 2022-06-16 雄大 田淵 中和可能コバレントドラッグ
EP4261285A1 (en) * 2020-12-08 2023-10-18 Yudai Tabuchi Neutralizable covalent drug
WO2022174102A1 (en) 2021-02-12 2022-08-18 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
TW202245843A (zh) 2021-02-12 2022-12-01 美商欣爍克斯公司 Il-2接合物及西米普利單抗(cemiplimab)之皮膚癌組合療法
WO2022256534A1 (en) 2021-06-03 2022-12-08 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
CN117980481A (zh) 2021-07-16 2024-05-03 阿普塔生物公司 用于基因表达调节的多核苷酸组合物和方法
CN113759107A (zh) * 2021-08-18 2021-12-07 苏州立禾生物医学工程有限公司 生物素标记缓冲液
CN114196714B (zh) * 2021-11-04 2023-09-29 华南理工大学 利用末端脱氧核糖核苷酸转移酶无模板合成含非天然碱基寡核苷酸链的方法及其应用
CN114031648A (zh) * 2021-11-08 2022-02-11 河南师范大学 一类非天然碱基三磷酸及其合成方法和应用
CN114249788B (zh) * 2021-12-17 2023-08-08 河南师范大学 非天然碱基核苷酸磷酸单酯类前药分子及其制备方法和应用
WO2023122573A1 (en) 2021-12-20 2023-06-29 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab

Family Cites Families (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5023243A (en) 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US4476301A (en) 1982-04-29 1984-10-09 Centre National De La Recherche Scientifique Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon
JPS5927900A (ja) 1982-08-09 1984-02-14 Wakunaga Seiyaku Kk 固定化オリゴヌクレオチド
FR2540122B1 (fr) 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
US4605735A (en) 1983-02-14 1986-08-12 Wakunaga Seiyaku Kabushiki Kaisha Oligonucleotide derivatives
US4948882A (en) 1983-02-22 1990-08-14 Syngene, Inc. Single-stranded labelled oligonucleotides, reactive monomers and methods of synthesis
US4824941A (en) 1983-03-10 1989-04-25 Julian Gordon Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
US4587044A (en) 1983-09-01 1986-05-06 The Johns Hopkins University Linkage of proteins to nucleic acids
US5118802A (en) 1983-12-20 1992-06-02 California Institute Of Technology DNA-reporter conjugates linked via the 2' or 5'-primary amino group of the 5'-terminal nucleoside
US5118800A (en) 1983-12-20 1992-06-02 California Institute Of Technology Oligonucleotides possessing a primary amino group in the terminal nucleotide
US5015733A (en) 1983-12-20 1991-05-14 California Institute Of Technology Nucleosides possessing blocked aliphatic amino groups
US4849513A (en) 1983-12-20 1989-07-18 California Institute Of Technology Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups
US5550111A (en) 1984-07-11 1996-08-27 Temple University-Of The Commonwealth System Of Higher Education Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
FR2567892B1 (fr) 1984-07-19 1989-02-17 Centre Nat Rech Scient Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
US5258506A (en) 1984-10-16 1993-11-02 Chiron Corporation Photolabile reagents for incorporation into oligonucleotide chains
US5430136A (en) 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5367066A (en) 1984-10-16 1994-11-22 Chiron Corporation Oligonucleotides with selectably cleavable and/or abasic sites
ZW17385A1 (en) 1984-11-06 1986-02-19 Hoffmann La Roche Tricyclic pyridine derivatives
US4828979A (en) 1984-11-08 1989-05-09 Life Technologies, Inc. Nucleotide analogs for nucleic acid labeling and detection
FR2575751B1 (fr) 1985-01-08 1987-04-03 Pasteur Institut Nouveaux nucleosides de derives de l'adenosine, leur preparation et leurs applications biologiques
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5185444A (en) 1985-03-15 1993-02-09 Anti-Gene Deveopment Group Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5166315A (en) 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5405938A (en) 1989-12-20 1995-04-11 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US4762779A (en) 1985-06-13 1988-08-09 Amgen Inc. Compositions and methods for functionalizing nucleic acids
US5093232A (en) 1985-12-11 1992-03-03 Chiron Corporation Nucleic acid probes
US4910300A (en) 1985-12-11 1990-03-20 Chiron Corporation Method for making nucleic acid probes
US5317098A (en) 1986-03-17 1994-05-31 Hiroaki Shizuya Non-radioisotope tagging of fragments
JPS638396A (ja) 1986-06-30 1988-01-14 Wakunaga Pharmaceut Co Ltd ポリ標識化オリゴヌクレオチド誘導体
US5264423A (en) 1987-03-25 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5276019A (en) 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
ATE113059T1 (de) 1987-06-24 1994-11-15 Florey Howard Inst Nukleosid-derivate.
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5188897A (en) 1987-10-22 1993-02-23 Temple University Of The Commonwealth System Of Higher Education Encapsulated 2',5'-phosphorothioate oligoadenylates
US4924624A (en) 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
US5525465A (en) 1987-10-28 1996-06-11 Howard Florey Institute Of Experimental Physiology And Medicine Oligonucleotide-polyamide conjugates and methods of production and applications of the same
DE3738460A1 (de) 1987-11-12 1989-05-24 Max Planck Gesellschaft Modifizierte oligonukleotide
US5082830A (en) 1988-02-26 1992-01-21 Enzo Biochem, Inc. End labeled nucleotide probe
EP0406309A4 (en) 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
US5278302A (en) 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
US5109124A (en) 1988-06-01 1992-04-28 Biogen, Inc. Nucleic acid probe linked to a label having a terminal cysteine
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5175273A (en) 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5262536A (en) 1988-09-15 1993-11-16 E. I. Du Pont De Nemours And Company Reagents for the preparation of 5'-tagged oligonucleotides
US5512439A (en) 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5599923A (en) 1989-03-06 1997-02-04 Board Of Regents, University Of Tx Texaphyrin metal complexes having improved functionalization
US5391723A (en) 1989-05-31 1995-02-21 Neorx Corporation Oligonucleotide conjugates
US4958013A (en) 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
US5451463A (en) 1989-08-28 1995-09-19 Clontech Laboratories, Inc. Non-nucleoside 1,3-diol reagents for labeling synthetic oligonucleotides
US5134066A (en) 1989-08-29 1992-07-28 Monsanto Company Improved probes using nucleosides containing 3-dezauracil analogs
US5254469A (en) 1989-09-12 1993-10-19 Eastman Kodak Company Oligonucleotide-enzyme conjugate that can be used as a probe in hybridization assays and polymerase chain reaction procedures
US5591722A (en) 1989-09-15 1997-01-07 Southern Research Institute 2'-deoxy-4'-thioribonucleosides and their antiviral activity
US5399676A (en) 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
CA2071510C (en) 1989-10-24 2004-07-06 Chris A. Buhr 2' modified oligonucleotides
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
US5264562A (en) 1989-10-24 1993-11-23 Gilead Sciences, Inc. Oligonucleotide analogs with novel linkages
US5292873A (en) 1989-11-29 1994-03-08 The Research Foundation Of State University Of New York Nucleic acids labeled with naphthoquinone probe
US5177198A (en) 1989-11-30 1993-01-05 University Of N.C. At Chapel Hill Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates
US5130302A (en) 1989-12-20 1992-07-14 Boron Bilogicals, Inc. Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same
US5486603A (en) 1990-01-08 1996-01-23 Gilead Sciences, Inc. Oligonucleotide having enhanced binding affinity
US5587361A (en) 1991-10-15 1996-12-24 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5646265A (en) 1990-01-11 1997-07-08 Isis Pharmceuticals, Inc. Process for the preparation of 2'-O-alkyl purine phosphoramidites
US5578718A (en) 1990-01-11 1996-11-26 Isis Pharmaceuticals, Inc. Thiol-derivatized nucleosides
US5587470A (en) 1990-01-11 1996-12-24 Isis Pharmaceuticals, Inc. 3-deazapurines
US5681941A (en) 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5459255A (en) 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
US5670633A (en) 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US5214136A (en) 1990-02-20 1993-05-25 Gilead Sciences, Inc. Anthraquinone-derivatives oligonucleotides
WO1991013080A1 (en) 1990-02-20 1991-09-05 Gilead Sciences, Inc. Pseudonucleosides and pseudonucleotides and their polymers
US5321131A (en) 1990-03-08 1994-06-14 Hybridon, Inc. Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling
WO1991014781A1 (en) 1990-03-19 1991-10-03 Henkel Research Corporation METHOD FOR INCREASING THE OMEGA-HYDROXYLASE ACTIVITY IN $i(CANDIDA TROPICALIS)
US5470967A (en) 1990-04-10 1995-11-28 The Dupont Merck Pharmaceutical Company Oligonucleotide analogs with sulfamate linkages
GB9009980D0 (en) 1990-05-03 1990-06-27 Amersham Int Plc Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
DK0455905T3 (da) 1990-05-11 1998-12-07 Microprobe Corp Dipsticks til nukleinsyrehybridiseringsassays og fremgangsmåde til kovalent immobilisering af oligonukleotider
US5677437A (en) 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5489677A (en) 1990-07-27 1996-02-06 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
US5608046A (en) 1990-07-27 1997-03-04 Isis Pharmaceuticals, Inc. Conjugated 4'-desmethyl nucleoside analog compounds
US5688941A (en) 1990-07-27 1997-11-18 Isis Pharmaceuticals, Inc. Methods of making conjugated 4' desmethyl nucleoside analog compounds
US5618704A (en) 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5218105A (en) 1990-07-27 1993-06-08 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
JPH0874B2 (ja) 1990-07-27 1996-01-10 アイシス・ファーマシューティカルス・インコーポレーテッド 遺伝子発現を検出および変調するヌクレアーゼ耐性、ピリミジン修飾オリゴヌクレオチド
US5623070A (en) 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5138045A (en) 1990-07-27 1992-08-11 Isis Pharmaceuticals Polyamine conjugated oligonucleotides
US5610289A (en) 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5541307A (en) 1990-07-27 1996-07-30 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs and solid phase synthesis thereof
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
WO1992002534A2 (en) 1990-08-03 1992-02-20 Sterling Drug, Inc. Compounds and methods for inhibiting gene expression
US5177196A (en) 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
US5512667A (en) 1990-08-28 1996-04-30 Reed; Michael W. Trifunctional intermediates for preparing 3'-tailed oligonucleotides
US5214134A (en) 1990-09-12 1993-05-25 Sterling Winthrop Inc. Process of linking nucleosides with a siloxane bridge
US5561225A (en) 1990-09-19 1996-10-01 Southern Research Institute Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages
WO1992005186A1 (en) 1990-09-20 1992-04-02 Gilead Sciences Modified internucleoside linkages
NZ239893A (en) 1990-09-25 1993-11-25 Hoechst Japan A method for introducing a foreign dna into a cell
US5432272A (en) 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
ATE198598T1 (de) 1990-11-08 2001-01-15 Hybridon Inc Verbindung von mehrfachreportergruppen auf synthetischen oligonukleotiden
US5672697A (en) 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5371241A (en) 1991-07-19 1994-12-06 Pharmacia P-L Biochemicals Inc. Fluorescein labelled phosphoramidites
US5571799A (en) 1991-08-12 1996-11-05 Basco, Ltd. (2'-5') oligoadenylate analogues useful as inhibitors of host-v5.-graft response
EP0538194B1 (de) 1991-10-17 1997-06-04 Novartis AG Bicyclische Nukleoside, Oligonukleotide, Verfahren zu deren Herstellung und Zwischenprodukte
US5594121A (en) 1991-11-07 1997-01-14 Gilead Sciences, Inc. Enhanced triple-helix and double-helix formation with oligomers containing modified purines
EP0637965B1 (en) 1991-11-26 2002-10-16 Isis Pharmaceuticals, Inc. Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
TW393513B (en) 1991-11-26 2000-06-11 Isis Pharmaceuticals Inc Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
US5484908A (en) 1991-11-26 1996-01-16 Gilead Sciences, Inc. Oligonucleotides containing 5-propynyl pyrimidines
US5359044A (en) 1991-12-13 1994-10-25 Isis Pharmaceuticals Cyclobutyl oligonucleotide surrogates
US5595726A (en) 1992-01-21 1997-01-21 Pharmacyclics, Inc. Chromophore probe for detection of nucleic acid
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
FR2687679B1 (fr) 1992-02-05 1994-10-28 Centre Nat Rech Scient Oligothionucleotides.
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
US5434257A (en) 1992-06-01 1995-07-18 Gilead Sciences, Inc. Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages
EP0577558A2 (de) 1992-07-01 1994-01-05 Ciba-Geigy Ag Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
US5272250A (en) 1992-07-10 1993-12-21 Spielvogel Bernard F Boronated phosphoramidate compounds
RU95114435A (ru) 1992-12-14 1997-05-20 Ханивелл Инк. (Us) Система с бесщеточным двигателем постоянного тока
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
US5476925A (en) 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups
GB9304618D0 (en) 1993-03-06 1993-04-21 Ciba Geigy Ag Chemical compounds
DK0691968T3 (da) 1993-03-30 1998-02-23 Sanofi Sa Acykliske nukleosid-analoge og oligonukleotidsekvenser indeholdende disse
EP0691977B1 (en) 1993-03-31 1997-11-26 Sanofi Oligonucleotides with amide linkages replacing phosphodiester linkages
EP0691979A1 (en) 1993-03-31 1996-01-17 Sanofi Novel 5'-substituted nucleosides and oligomers produced therefrom
DE4311944A1 (de) 1993-04-10 1994-10-13 Degussa Umhüllte Natriumpercarbonatpartikel, Verfahren zu deren Herstellung und sie enthaltende Wasch-, Reinigungs- und Bleichmittelzusammensetzungen
GB9311682D0 (en) 1993-06-05 1993-07-21 Ciba Geigy Ag Chemical compounds
US5502177A (en) 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
US5457187A (en) 1993-12-08 1995-10-10 Board Of Regents University Of Nebraska Oligonucleotides containing 5-fluorouracil
US5446137B1 (en) 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
US5519134A (en) 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5596091A (en) 1994-03-18 1997-01-21 The Regents Of The University Of California Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
US5627053A (en) 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5625050A (en) 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5597909A (en) 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5580731A (en) 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
GB9606158D0 (en) 1996-03-23 1996-05-29 Ciba Geigy Ag Chemical compounds
US7875733B2 (en) 2003-09-18 2011-01-25 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
AU6024998A (en) 1997-01-15 1998-08-07 Glycomed Incorporated Aryl c-glycoside compounds and sulfated esters thereof
US6770748B2 (en) 1997-03-07 2004-08-03 Takeshi Imanishi Bicyclonucleoside and oligonucleotide analogue
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
EP1557424A1 (en) 1997-09-12 2005-07-27 Exiqon A/S Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues
US6955807B1 (en) 1998-05-15 2005-10-18 Bayer Pharmaceuticals Corporation IL-2 selective agonists and antagonists
US6562798B1 (en) 1998-06-05 2003-05-13 Dynavax Technologies Corp. Immunostimulatory oligonucleotides with modified bases and methods of use thereof
US6175001B1 (en) * 1998-10-16 2001-01-16 The Scripps Research Institute Functionalized pyrimidine nucleosides and nucleotides and DNA's incorporating same
NZ514348A (en) 1999-05-04 2004-05-28 Exiqon As L-ribo-LNA analogues
US6525191B1 (en) 1999-05-11 2003-02-25 Kanda S. Ramasamy Conformationally constrained L-nucleosides
US7101992B1 (en) 1999-07-15 2006-09-05 Japan Science And Technology Agency Nucleic acid base pair
AU1239901A (en) 1999-10-29 2001-05-14 Stratagene Compositions and methods utilizing dna polymerases
WO2002062816A1 (en) 2001-02-07 2002-08-15 Celltech R & D Limited Non-natural nucleotides and dinucleotides
MXPA03007853A (es) 2001-03-01 2004-05-24 Pharmasset Ltd Metodo para la sintesis de 2',3'-didesoxi-2',3'-dideshidronucleosidos.
AUPR975201A0 (en) * 2001-12-24 2002-01-24 Unisearch Limited Enzymatic redox labelling of nucleic acids
US20060074035A1 (en) 2002-04-17 2006-04-06 Zhi Hong Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections
EP1544294B8 (en) 2002-07-17 2014-03-19 Riken Nucleosides or nucleotides having novel unnatural bases and use thereof
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
AU2003290596B2 (en) 2002-11-05 2011-05-12 Isis Pharmaceuticals, Inc. Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
WO2004106356A1 (en) 2003-05-27 2004-12-09 Syddansk Universitet Functionalized nucleotide derivatives
EP1661905B9 (en) 2003-08-28 2012-12-19 IMANISHI, Takeshi Novel artificial nucleic acids of n-o bond crosslinkage type
JP4956802B2 (ja) 2003-09-10 2012-06-20 独立行政法人理化学研究所 非天然型塩基を有するヌクレオシド又はヌクレオチド及びその利用
US7348146B2 (en) * 2003-10-02 2008-03-25 Epoch Biosciences, Inc. Single nucleotide polymorphism analysis of highly polymorphic target sequences
DK2145956T3 (da) 2003-11-03 2015-09-21 Medical Res Council Polymerase
BRPI0507169A (pt) 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
WO2006049297A1 (ja) 2004-11-08 2006-05-11 Riken 新規なヌクレオシド若しくはヌクレオチド誘導体及びその利用
JP5649018B2 (ja) 2005-08-04 2015-01-07 タグシクス・バイオ株式会社 新規人工塩基対及びその利用
KR101404374B1 (ko) 2005-12-09 2014-06-09 도꾸리쯔교세이호징 리가가쿠 겐큐소 핵산의 복제방법 및 신규한 인공 염기쌍
DK1984381T3 (da) 2006-01-27 2010-11-01 Isis Pharmaceuticals Inc 6-modificerede bicycliske nukleinsyreanaloger
WO2007085485A2 (en) * 2006-01-27 2007-08-02 Santaris Pharma A/S Lna modified phosphorothiolated oligonucleotides
BRPI0707722A2 (pt) 2006-02-14 2011-05-10 Basf Se compostos, processo para a preparaÇço de compostos, composiÇço agrÍcola, uso de compostos, mÉtodos para combater fungos fitopatogÊnicos, para combater pestes artràpedes, para proteger culturas de ataque ou infestaÇço por pestes artràpedes, para proteger sementes da infestaÇço por pestes artràpedes e das raÍzes e rebentos de mudas da infestaÇço por pestes artràpodes, e para proteger materiais nço-vivos do ataque ou infestaÇço por pestes artràpedes, e, semente
EP1992698B1 (en) 2006-02-22 2018-09-05 Riken METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT
US20140314864A1 (en) 2006-03-31 2014-10-23 Massachusetts Institute Of Technology System for Targeted Delivery of Therapeutic Agents
CA2651453C (en) 2006-05-11 2014-10-14 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
EP2126083A1 (en) * 2006-12-06 2009-12-02 Erik Bjerregaard Pedersen Hoogsteen-type triplex formation of pyrene labelled probes for nucleic acid detection in fluorescence assay
EP2125852B1 (en) 2007-02-15 2016-04-06 Ionis Pharmaceuticals, Inc. 5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
KR101551985B1 (ko) 2007-03-09 2015-09-09 리가가쿠 겐큐쇼 모노뉴클레오시드 또는 모노뉴클레오티드로부터 유도되는 구조를 갖는 화합물, 핵산, 표지 물질, 핵산 검출 방법 및 키트
US8278425B2 (en) 2007-05-30 2012-10-02 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
DK2173760T4 (en) 2007-06-08 2016-02-08 Isis Pharmaceuticals Inc Carbocyclic bicyclic nukleinsyreanaloge
US8278283B2 (en) 2007-07-05 2012-10-02 Isis Pharmaceuticals, Inc. 6-disubstituted or unsaturated bicyclic nucleic acid analogs
US8546556B2 (en) 2007-11-21 2013-10-01 Isis Pharmaceuticals, Inc Carbocyclic alpha-L-bicyclic nucleic acid analogs
KR101556426B1 (ko) 2008-03-31 2015-10-02 탁시스 바이오 가부시키가이샤 고선택ㆍ고효율로 pcr 증폭이 가능한 신규 dna
US8501805B2 (en) 2008-09-24 2013-08-06 Isis Pharmaceuticals, Inc. Substituted alpha-L-bicyclic nucleosides
US8895712B2 (en) 2009-10-06 2014-11-25 Riken Artificial base pair capable of forming specific base pair
EP2625186B1 (en) 2010-04-28 2016-07-27 Ionis Pharmaceuticals, Inc. 5' modified nucleosides and oligomeric compounds prepared therefrom
KR102591732B1 (ko) 2010-11-12 2023-10-19 넥타르 테라퓨틱스 Il-2 부분 및 중합체의 접합체
DK3489255T3 (da) 2011-02-10 2021-08-23 Roche Glycart Ag Muterede interleukin-2-polypeptider
US8343752B2 (en) 2011-05-03 2013-01-01 Verdezyne, Inc. Biological methods for preparing adipic acid
AU2014306271A1 (en) * 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
EP3943607A1 (en) 2014-04-09 2022-01-26 The Scripps Research Institute Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
US20170369871A1 (en) 2015-01-12 2017-12-28 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
ES2929047T3 (es) 2016-06-24 2022-11-24 Scripps Research Inst Transportador de nucleósido trifosfato novedoso y usos del mismo
US20200224234A1 (en) 2017-07-11 2020-07-16 The Scripps Research Institute Incorporation of unnatural nucleotides and methods of use in vivo thereof
AR112756A1 (es) 2017-07-11 2019-12-11 Synthorx Inc Incorporación de nucleótidos no naturales, y su método
MA51430A (fr) 2017-12-29 2020-11-04 Scripps Research Inst Compositions de paire de bases non naturelles et procédés d'utilisation
AU2020291535A1 (en) 2019-06-14 2022-01-20 The Scripps Research Institute Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
WO2021067313A1 (en) 2019-09-30 2021-04-08 The Scripps Research Institute Eukaryotic semi-synthetic organisms
TW202128996A (zh) 2019-10-10 2021-08-01 美商史基普研究協會 用於活體內合成非天然多肽的組合物及方法
AU2021364920A1 (en) 2020-10-23 2023-06-22 Synthorx, Inc. Reverse transcription of polynucleotides comprising unnatural nucleotides

Similar Documents

Publication Publication Date Title
JP2022003044A5 (ja)
JP2023073507A5 (ja)
JP2023113843A5 (ja)
JP4527789B2 (ja) 増加した標的特異的tmを持つ修飾オリゴヌクレオチドを用いた核酸配列の検出および増幅のための方法
JP2020508037A5 (ja) 親和性試薬を使用する核酸シークエンシング
RU98105786A (ru) Модифицированные праймеры
JP2021074021A5 (ja)
RU2019141655A (ru) Композиции и способы химического расщепления и снятия защиты для связанных с поверхностью олигонуклеотидов
RU2019123609A (ru) Способ секвенирования на основе одного флуоресцентного красителя
JP2005517432A5 (ja)
JP2012502657A5 (ja)
JP2005517452A5 (ja)
JP2018512041A5 (ja)
JP2011250796A5 (ja)
JP2010530759A5 (ja)
DK1470144T3 (da) Oligonukleotider omfattende alternerende segmenter og anvendelser deraf
JP2009524696A5 (ja)
JP6971276B2 (ja) クランプオリゴヌクレオチドを利用する核酸増幅方法
JP2010512169A5 (ja)
Sørensen et al. Functionalized LNA (locked nucleic acid): high-affinity hybridization of oligonucleotides containing N-acylated and N-alkylated 2′-amino-LNA monomers
JP2021506246A5 (ja)
WO2004074300A3 (en) Novel photolabile protective groups for improved processes to prepare oligonucleotide arrays
JP2016513951A (ja) 交替式捕捉トランスレータ
JPWO2020158687A5 (ja)
JP2006521824A5 (ja)